What exactly occurs at the molecular level in the human organism when cannabis plant compounds are consumed? The answer lies in one of the most complex regulatory systems in physiology: the endocannabinoid system (ECS). This network was only discovered in the 1990s during receptor research on plant-based active compounds.
📑 Inhaltsverzeichnis
- The Endocannabinoid System: An Internal Regulatory Network
- THC: Molecular Mimicry and the Neurological Cascade
- Metabolism: Why Oral Consumption Produces Stronger Effects
- CBD: The Allosteric Modulator Without Intoxication
- The Significance of Terpenes for the Effects Profile
- Toxicology and Physiological Limits
- Frequently Asked Questions About Pharmacodynamics
- 💬 Fragen? Frag den Hanf-Buddy!
Today, it is scientifically established that the ECS plays a fundamental role in maintaining homeostasis—it regulates pain perception, emotional state, appetite control, sleep cycles, and immune response. Active compounds like THC and CBD interact with this system because the body produces structurally similar endogenous messenger molecules.
The Endocannabinoid System: An Internal Regulatory Network
The human organism possesses a specific system of receptors, ligands, and enzymes. Research primarily distinguishes two types of G-protein-coupled receptors:
CB1 Receptors: These are present in the highest density in the central nervous system, particularly in the hippocampus, basal ganglia, and cerebellum. They modulate neurotransmitter release and are responsible for the psychoactive effects of THC as well as cognitive processes and pain control.
CB2 Receptors: These are found predominantly on immune system cells, in the spleen, and in peripheral tissues. They play a major role in regulating inflammatory responses and immune functions.
The body synthesizes its own molecules as needed—called endocannabinoids—which function as retrograde messengers. The most well-known is arachidonoyl ethanolamine, also called anandamide (derived from the Sanskrit word „ananda“ meaning bliss). It binds with high affinity to CB1 receptors. A second essential molecule is 2-arachidonoyl glycerol (2-AG), which is present in higher concentrations in the brain and activates both receptor types.
THC: Molecular Mimicry and the Neurological Cascade
Delta-9-tetrahydrocannabinol (THC) is the primary phytocannabinoid of the plant. Due to its structural similarity to anandamide, it functions as a partial agonist at CB1 receptors. Unlike the body’s own messengers, which are immediately broken down enzymatically (by FAAH or MAGL) after signal transmission, THC remains at the receptor much longer and activates it far more intensely.
This overstimulation disrupts normal neural communication. In brain areas responsible for time perception and memory, this produces the typical intoxication experience. When inhaled, THC crosses the alveolar-capillary barrier of the lungs in seconds. The lipophilicity of the molecule enables rapid passage across the blood-brain barrier. While the plasma concentration reaches its maximum in about ten minutes, the psychotropic effect lags slightly behind, as the molecule must first accumulate in the brain’s fatty tissue.
Metabolism: Why Oral Consumption Produces Stronger Effects
Oral consumption of cannabis-containing foods follows a completely different pharmacokinetic pathway. After absorption in the gastrointestinal tract, THC undergoes the first-pass effect in the liver. There, the enzyme cytochrome P450 transforms delta-9-THC into 11-hydroxy-THC.
This metabolite possesses higher affinity for the CB1 receptor and is significantly more potent than the parent compound. Additionally, 11-hydroxy-THC crosses the blood-brain barrier even more efficiently. This explains the delayed onset (30 to 90 minutes) but substantially more intense and longer-lasting effect (up to eight hours) that edibles often produce, leading to frequent misjudgments of dosage.
CBD: The Allosteric Modulator Without Intoxication
Cannabidiol (CBD) occupies a special position. It has low binding affinity to the classical CB1 and CB2 receptors and therefore does not produce intoxication. Instead, it acts as a negative allosteric modulator at the CB1 receptor. This means it changes the shape of the receptor so that THC binds less effectively—CBD thus acts as a natural buffer against the psychoactive peaks of THC.
Furthermore, CBD inhibits the enzyme FAAH, which is responsible for breaking down the body’s endogenous anandamide. This increases the level of the natural „bliss molecule“ in the synaptic cleft. The anxiety-relieving effects of CBD are also explained by the activation of serotonin receptors (5-HT1A) and vanilloid receptors (TRPV1). The complex interplay of all compounds is referred to in research as the entourage effect.
The Significance of Terpenes for the Effects Profile
In addition to the main active compounds, the plant produces over 200 terpenes. These volatile aromatic compounds are far more than just fragrances; they are highly pharmacologically active.
Myrcene increases the permeability of the blood-brain barrier to other active compounds and produces muscle relaxation. Limonene demonstrates mood-lifting properties in studies. Beta-caryophyllene is particularly interesting because it acts directly as an agonist at the CB2 receptor and thus supports anti-inflammatory processes without affecting the central nervous system. Modern science therefore considers the entire chemical profile (chemovar) of a strain as decisive for therapeutic effects, rather than merely distinguishing between botanical classifications like Sativa or Indica.
Toxicology and Physiological Limits
Pharmacologically, the plant is considered safe because the brainstem—the control center for heartbeat and respiration—has few CB1 receptors. Respiratory depression, as can occur with opioids, is therefore impossible. Nevertheless, acute sympathomimetic effects such as tachycardia (elevated heart rate), conjunctival injection (red eyes), and xerostomia (dry mouth) do occur.
Clinical research particularly warns against consumption during adolescence. Since the ECS plays a major role in brain maturation and the formation of neural networks, exogenous administration of active compounds during this phase can have lasting effects on cognitive development. Additionally, in those with appropriate predisposition, there is an increased risk of psychotic disorders manifesting.
Frequently Asked Questions About Pharmacodynamics
Does Consumption Lead to Physical Dependence?
Severe physical dependence with life-threatening withdrawal symptoms is unknown. However, down-regulation of receptors can occur (tolerance development). With chronic use and sudden cessation, affected individuals report sleep disturbances, appetite loss, and inner restlessness, suggesting psychological dependence. These symptoms typically normalize within two weeks as receptor density regenerates.
Why Does the Effect Vary So Greatly Between Individuals?
Genetics play a decisive role. The distribution and number of receptors, as well as the efficiency of degrading enzymes, are genetically determined. Body fat percentage also influences the storage of lipophilic compounds. Psychological baseline state and environment (set and setting) further modulate subjective experience through interaction with other neurotransmitters like dopamine and serotonin.
How Long Are Effects Detectable in the Body?
Wie gut kennst du das Endocannabinoid-System in deinem Körper?
While the psychotropic effect subsides after two to four hours when inhaled, metabolic byproducts remain in the body much longer due to their fat solubility. They are stored temporarily in fatty tissue and slowly excreted through urine and feces. In occasional users, metabolic products are detectable for approximately two to four days; in chronic users, for several weeks, even though no acute impairment is present.
Branchen-Update
News, Analysen und Reportagen — mehrmals im Monat direkt in dein Postfach.
Folge uns
